Quoin Pharmaceuticals, Ltd. (QNRX)

$4.72

-0.06 (-1.26%)
Rating:
Recommendation:
-
Symbol QNRX
Price $4.72
Beta 0.000
Volume Avg. 1.51M
Market Cap 6.778M
Shares () -
52 Week Range 3.58-444.0
1y Target Est -
DCF Unlevered QNRX DCF ->
DCF Levered QNRX LDCF ->
ROE 82.57% Strong Buy
ROA -348.28% Strong Sell
Operating Margin -
Debt / Equity -111.34% Sell
P/E -
P/B -0.20 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest QNRX news


Healthcare
Biotechnology
NASDAQ Capital Market

Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome. The company also offers three other pipeline products in development, which are also targeting rare skin diseases, including epidermolysis bullosa, Netherton Syndrome, and Scleroderma. Quoin Pharmaceuticals, Ltd. was incorporated in 2018 and is based in Ashburn, Virginia.